NorthWest Biotherapeutics Inc (NWBO)

[Dan88]

Now I seem to understand more of why the company has been so bizarre and out of norms for so long; it appears that the company not only has a horrendous naked shorting wolfpack to deal with but a foe so formidable, which might be its regulatory body FDA, that explains some of the reason for the partial halt: FDA might for what reason suggested to the company to start a new trial due to the length of the trial and maybe some changes in trial protocol, which also involved manufacturing change (optimization), etc.

The good thing is the halt was lifted, meaning FDA finally went the company's way with a weary eye fixed on the company.

The company, still in shock, wants to have a sure hand in dealing with FDA in terms of finally asking for its approval: the company wants to show as good as possible results to FDA, or the company kinds of waits for FDA to correct its previous wrong in dealing with the company by suggesting to the company: the data is better enough, stop the trial!

So aware of any possible regulatory passage ways, old and new, the company chooses silence because it for itself really doesn't know which way is the more plausible way based on its previous unpleasant experience with FDA. So keeping quiet in this front is the best way forward.

To conclude, today's buyout news shall serve as a mirror to that will be potential price of nwbo, considering nwbo is much much more broad and applicable in treating all solid cancers.

Celgene to acquire Juno Therapeutics for $9 billion, or $87 a share
Sanofi to acquire Bioverativ for $11.6 billion

If we have the same offer, our price shall be in the range of $12 _ 20.